Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1

Experimental Parasitology

Volumn 127, Issue 2, 2011, Pages 423-428

  Dodson, Heidi C ^a   Lyda, Todd A ^a,b   Chambers, Jeremy W ^a,c   Morris, Meredith T ^a   Christensen, Kenneth A ^a   Morris, James C ^a  

^a CLEMSON UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Glycolysis; Hexokinase; Quercetin; Trypanosoma brucei

Indexed keywords

GLUCOSE; HEXOKINASE 1; QUERCETIN; TRYPTOPHAN;

ARTICLE; ENZYME BINDING; ENZYME INHIBITION; FLUORESCENCE; GLYCOSOME; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SPECTROSCOPY; TRYPANOSOMA BRUCEI;

ENZYME INHIBITORS; FLAVONOIDS; HEXOKINASE; MICROBODIES; MICROSCOPY, FLUORESCENCE; PILOT PROJECTS; QUERCETIN; RECOMBINANT PROTEINS; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI;

MAMMALIA; TRYPANOSOMA BRUCEI;

EID: 78751576238     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.10.011     Document Type: Article

References (32)

1. Albert M.A., Haanstra J.R., Hannaert V., Van Roy J., Opperdoes F.R., Bakker B.M., Michels P.A. Experimental and in silico analyses of glycolytic flux control in bloodstream form Trypanosoma brucei. J. Biol. Chem. 2005, 280:28306-28315.
2. Barrett M.P., Burchmore R.J., Stich A., Lazzari J.O., Frasch A.C., Cazzulo J.J., Krishna S. The trypanosomiases. Lancet. 2003, 362:1469-1480.
3. Blattner J., Dorsam H., Clatyon C.E. Function of N-terminal import signals in trypanosome microbodies. FEBS Lett. 1995, 360:310-314.
4. Boege F., Straub T., Kehr A., Boesenberg C., Christiansen K., Andersen A., Jakob F., Kohrle J. Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J. Biol. Chem. 1996, 271:2262-2270.
5. Bryson J.M., Coy P.E., Gottlob K., Hay N., Robey R.B. Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J. Biol. Chem. 2002, 277:11392-11400.
6. Chambers J.W., Fowler M.L., Morris M.T., Morris J.C. The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1. Mol. Biochem. Parasitol. 2008, 158:202-207.
7. Chambers J.W., Kearns M.T., Morris M.T., Morris J.C. Assembly of heterohexameric trypanosome hexokinases reveals that hexokinase 2 is a regulable enzyme. J. Biol. Chem. 2008, 283:14963-14970.
8. Colasante C., Ellis M., Ruppert T., Voncken F. Comparative proteomics of glycosomes from bloodstream form and procyclic culture form Trypanosoma brucei brucei. Proteomics 2006, 6:3275-3293.
9. Floridi A., Lehninger A.L. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch. Biochem. Biophy. 1983, 226:73-83.
10. Gottlob K., Majewski N., Kennedy S., Kandel E., Robey R.B., Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 2001, 15:1406-1418.
11. Granot Y. The ATP site of protein kinases as target for drug development: from natural compounds to gleevec. Isr. Med. Assoc. J. 2002, 4:633-635.
12. Graziani Y. Bioflavonoid regulation of ATPase and hexokinase activity in Ehrlich ascites cell mitochondria. Biochim. Biophy. Acta 1977, 460:364-373.
13. Graziani Y., Erikson E., Erikson R.L. The effect of quercetin on the phosphorylation activity of the Rous sarcoma virus transforming gene product in vitro and in vivo. Eur. J. Biochem. 1983, 135:583-589.
14. Guharay J., Sengupta B., Sengupta P.K. Protein-flavonol interaction: fluorescence spectroscopic study. Proteins 2001, 43:75-81.
15. Hu C.C., Chen W.K., Liao P.H., Yu W.C., Lee Y.J. Synergistic effect of cadmium chloride and acetaldehyde on cytotoxicity and its prevention by quercetin and glycyrrhizin. Mutat. Res. 2001, 496:117-127.
16. Kuser P.R., Krauchenco S., Antunes O.A., Polikarpov I. The high resolution crystal structure of yeast hexokinase PII with the correct primary sequence provides new insights into its mechanism of action. J. Biol. Chem. 2000, 275:20814-20821.
17. Mamani-Matsuda M., Rambert J., Malvy D., Lejoly-Boisseau H., Daulouede S., Thiolat D., Coves S., Courtois P., Vincendeau P., Mossalayi M.D. Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages. Antimicrob. Agents Chemother. 2004, 48:924-929.
18. Marchetti M.A., Tschudi C., Kwon H., Wolin S.L., Ullu E. Import of proteins into the trypanosome nucleus and their distribution at karyokinesis. J. Cell Sci. 2000, 113(Pt 5):899-906.
19. Matter W.F., Brown R.F., Vlahos C.J. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem. Biophy. Res. Commun. 1992, 186:624-631.
20. Misset O., Opperdoes F.R. Simultaneous purification of hexokinase, class-I fructose-bisphosphate aldolase, triosephosphate isomerase and phosphoglycerate kinase from Trypanosoma brucei. Eur. J. Biochem. 1984, 144:475-483.
21. Mittra B., Saha A., Chowdhury A.R., Pal C., Mandal S., Mukhopadhyay S., Bandyopadhyay S., Majumder H.K. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol. Med. 2000, 6:527-541.
22. Molnar J., Beladi I., Domonkos K., Foldeak S., Boda K., Veckenstedt A. Antitumor activity of flavonoids on NK/Ly ascites tumor cells. Neoplasma 1981, 28:11-18.
23. Morris J.C., Wang Z., Drew M.E., Englund P.T. Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library. EMBO J. 2002, 21:4429-4438.
24. Morris M.T., DeBruin C., Yang Z., Chambers J.W., Smith K.S., Morris J.C. Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail. Eukaryot. Cell 2006, 5:2014-2023.
25. Motyka S.A., Drew M.E., Yildirir G., Englund P.T. Overexpression of a cytochrome b5 reductase-like protein causes kinetoplast DNA loss in Trypanosoma brucei. J. Biol. Chem. 2006, 281:18499-18506.
26. Paggi, M.G., Fanciulli, M., Perrotti, N., Floridi, A., Zeuli, M., Silvestrini, B., Caputo, A., 1988. The role of mitochondrial hexokinase in neoplastic phenotype and its sensitivity to lonidamine. Ann. N Y Acad. Sci. 551, 358-360.
27. Sengupta B., Sengupta P.K. The interaction of quercetin with human serum albumin: a fluorescence spectroscopic study. Biochem. Biophy.Res. Commun. 2002, 299:400-403.
28. Sharlow E.R., Lyda T.A., Dodson H.C., Mustata G., Morris M.T., Leimgruber S.S., Lee K.H., Kashiwada Y., Close D., Lazo J.S., Morris J.C. A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity. PLoS Neglected Tropical Diseases 2010, 4:e659.
29. Srivastava A.K. Inhibition of phosphorylase kinase, and tyrosine protein kinase activities by quercetin. Biochem. Biophy. Res. Commun. 1985, 131:1-5.
30. Suolinna E.M., Buchsbaum R.N., Racker E. The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res. 1975, 35:1865-1872.
31. Wang Z., Morris J.C., Drew M.E., Englund P.T. Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters. J. Biol. Chem. 2000, 275:40174-40179.
32. Willson M., Sanejouand Y.H., Perie J., Hannaert V., Opperdoes F. Sequencing, modeling, and selective inhibition of Trypanosoma brucei hexokinase. Chem. Biol. 2002, 9:839-847.